Research highlights on kidney transplantation in 2021: voices from China
10.3969/j.issn.1674-7445.2022.03.007
- VernacularTitle:2021年肾移植研究大盘点：来自中国的声音
- Author:
Zihuan LUO
1
;
Qiquan SUN
Author Information
1. Department of Kidney Transplantation, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China
- Publication Type:Research Article
- Keywords:
Kidney transplantation;
Ischemia-reperfusion injury;
Infection;
Immunosuppressant;
Inflammation;
Chronic renal allograft dysfunction;
Antibody-mediated rejection;
T cell-mediated rejection
- From:
Organ Transplantation
2022;13(3):325-
- CountryChina
- Language:Chinese
-
Abstract:
Over the past 70 years, kidney transplantation has become not only the most mature but also the highest-success-rate surgery among all organ transplantation surgeries. However, the long-term survival of kidney transplant recipients is still challenged by such key factors as ischemia-reperfusion injury related to kidney transplantation, rejection, chronic renal allograft dysfunction, renal allograft fibrosis, immunosuppressive therapy, infections and others. Relevant fundamental and clinical studies have emerged endlessly. At the same time, the research related to kidney transplantation also becomes a new hot spot accordingly in the context of the normalization of novel coronavirus pneumonia. This article reviewed the cutting-edge hot spots in relation to the fundamental and clinical aspects of kidney transplantation together with relevant new techniques and new visions. The studies included in this article focused on the reports published by Chinese teams that are more applicable to the current situation of kidney transplantation in China, for the purpose of providing new thoughts and strategies for the diagnosis and treatment of kidney transplantation related issues in China.
